Vascular endothelial growth factor acted as autocrine growth factor in an acute promyelocytic leukemia case

Leukemia and Lymphoma

Volumn 51, Issue 4, 2010, Pages 717-719

  Oka, Yoko ^a   Tashiro, Haruko ^a   Shirasaki, Ryosuke ^a   Sugao, Toshihiko ^a   Nishi, Ryuichi ^a   Akiyama, Nobu ^a   Kawasugi, Kazuo ^a   Fujimori, Shin ^a   Shirafuji, Naoki ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; RETINOIC ACID; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ADULT; AUTOCRINE EFFECT; BONE MARROW CELL; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG RESPONSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN CELL; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTOSIS; PETECHIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AUTOCRINE COMMUNICATION; CELL PROLIFERATION; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, PROMYELOCYTIC, ACUTE; RECURRENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77953225041     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428191003672131     Document Type: Letter

References (14)

1. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006;312:549-560.
2. Gerber H-P, Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J Mol Med 2003;81:20-31.
3. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1p stem cells from bone-marrow microenvironment. Nat Med 2002;8:841-849.
4. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1994;1221:211-214.
5. Bellamy WT, Richter L, Sirjani D, et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001;97: 1427-1434.
6. Kini AR, Peterson LC, Tallman MS, Lingen MW. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood 2001;97:3919-3924.
7. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000;95:309-313.
8. Fiedler W, Graeven U, Ergün S, et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997;89:1870-1875.
9. Shirafuji N, Takahashi S, Matsuda S, Asano S. Mitochondrial antisense RNA for cytochrome C oxidase (MARCO) can induce morphologic changes and cell death in human hematopoietic cell lines. Blood 1997;90:4567-4577.
10. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001;98:1904-1913.
11. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
12. Terman BI, Dougher-Vermazen JM, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579-l586.
13. Iljin K, Karkkainen MJ, Lawrence EC, et al. VEGFR3 gene structure, regulatory region, and sequence polymorphisms. FASEB J 2001;15:1028-1036.
14. Aguayo A, Estey E, Kantarjian H, et al. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia. Blood 1999;94:3717-3721.